Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL) — Stella

Recruiting

Back to RSV trials

Trial locations(1 site)

Chile

ISCI, Santiago

Key details

Sponsor

Instituto Sistemas Complejos de Ingeniería

Enrollment target

~160,000 participants

Started

April 2024

Primary completion

October 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov